Patents by Inventor Jiecheng ZHANG

Jiecheng ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250020109
    Abstract: A cascaded energy storage system includes: a gas storage which is divided into at least one air chamber and at least one working medium gas chamber by a flexible diaphragm, where pressure of the air chamber is equal to pressure of the working medium gas chamber, and volume of the air chamber and volume of the working medium gas chamber is capable of being adjusted by contraction and expansion of the flexible diaphragm; an air compression and energy release assembly which communicates with the air chamber, and is configured to introduce compressed air into the air chamber and release the compressed air; a working medium gas-liquid conversion assembly including a working medium compression assembly, a working medium expansion assembly and a liquid storage assembly; and a heat storage assembly, configured to release heat or store heat to the working medium gas-liquid conversion assembly.
    Type: Application
    Filed: September 29, 2024
    Publication date: January 16, 2025
    Applicant: XECA TURBO (CHENGDU) TECHNOLOGY CO., LTD
    Inventors: Xuefeng ZHANG, Jiecheng CHI, Kaiyun ZHENG, Guohua YU, Mengying SHU, Lin TAO, Jiangtao BAI
  • Patent number: 10329328
    Abstract: A fusion protein has a first antigen element, a second antigen element, and optionally a tag sequence and/or a signal peptide sequence. The first antigen element includes a polypeptide derived from the Mycobacterium tuberculosis Psts-1 protein. The second antigen element includes a polypeptide derived from a protein encoded by a HPV gene. The fusion protein can induce humoral immunity and cellular immunity to a high-risk HPV cancer protein and has anti-cancer activity in vivo.
    Type: Grant
    Filed: December 28, 2015
    Date of Patent: June 25, 2019
    Assignee: ATTOGEN BIOMEDICAL (SUZHOU) INC. LTD.
    Inventors: Xiaojia Chang, Chenglong Shi, Lijun Shi, Jiecheng Zhang
  • Publication number: 20170349633
    Abstract: The present invention provides a fusion protein comprising an HPV cancer-causing protein segment, a coding sequence thereof and an application thereof in preparing drugs for detecting or treating HPV-related diseases. The fusion protein can simultaneously induce the humoral immunity and the cellular immunity for a high-risk HPV cancer protein and has anti-cancer activity in vivo.
    Type: Application
    Filed: December 28, 2015
    Publication date: December 7, 2017
    Inventors: Xiaojia CHANG, Chenglong SHI, Lijun SHI, Jiecheng ZHANG
  • Patent number: D1020901
    Type: Grant
    Filed: December 25, 2023
    Date of Patent: April 2, 2024
    Inventor: Jiecheng Zhang
  • Patent number: D1038132
    Type: Grant
    Filed: April 16, 2024
    Date of Patent: August 6, 2024
    Inventor: Jiecheng Zhang